NCT02943317 2019-04-30Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian CancerVerastem, Inc.Phase 1 Terminated98 enrolled